本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

65.07
+0.16000.25%
盘后65.070.00000.00%16:11 EDT
成交量:22.46万
成交额:1,461.60万
市值:14.10亿
市盈率:-62.39
高:66.08
开:64.92
低:64.36
收:64.91
数据加载中...
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/04/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities